Logo

FDA Clears Zymo Research Coronavirus Sample Collection Device

Mar 11, 2021 | staff reporter

NEW YORK — Zymo Research said on Thursday that it has received 510(k) clearance from the US Food and Drug Administration for its DNA/RNA Shield Collection Tube, allowing its use for SARS-CoV-2 testing.

According to Zymo, the product consists of a tube filled with proprietary transport medium that stabilizes SARS-CoV-2 RNA for up to 28 days at ambient temperatures. The tube may be kitted with a swab or sputum collection kit, the company said.

Last year, Irvine, California-based Zymo received CE-IVD marking for the DNA/RNA Shield Collection Tube, as well as two other sample collection devices.

Filed under

Molecular Diagnostics
Infectious Disease
Sample Preparation
COVID-19
510(k)
North America
coronavirus
Zymo Research
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.